Insider · CIK 0001211404

BROOKS JOEL

Reports to the SEC for 2 companies · NEW BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001211404

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-10-16	CANTALOUPE, INC.A Award	Director	AAward	+13.2K sh	—	—	92,570
2018-07-02	CANTALOUPE, INC.A Award	Director	AAward	+6,677 sh	—	—	79,354
2017-07-01	CANTALOUPE, INC.A Award	Director	AAward	+16.4K sh	—	—	72,677
2016-07-01	CANTALOUPE, INC.A Award	Director	AAward	+9,479 sh	—	—	56,313
2016-07-01	CANTALOUPE, INC.A Award	Director	AAward	+9,479 sh	—	—	56,313
2015-08-01	CANTALOUPE, INC.A Award	Director	AAward	+11.8K sh	—	—	46,834
2014-11-18	ELOXEloxx Pharmaceuticals, Inc. · Common Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+28.1K sh	—	—	47,300
2013-09-13	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionA Award	Chief Financial Officer	AAward	+985K sh	—	—	2,177,200
2012-11-16	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionsA Award	Chief Financial Officer	AAward	+780K sh	—	—	1,797,200
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+100 sh	$1.36	+$136	29,897
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+4,000 sh	$1.35	+$5,400	14,000
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+8,897 sh	$1.35	+$12K	22,897
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+2,300 sh	$1.35	+$3,105	25,197
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+4,600 sh	$1.35	+$6,210	29,797
2012-05-24	CANTALOUPE, INC.P Purchase	Director	PPurchase	+5,103 sh	$1.37	+$6,991.11	35,000
2011-09-30	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionA Award	Chief Financial Officer	AAward	+468K sh	—	—	1,325,500
2011-06-30	CANTALOUPE, INC.A Award	Director	AAward	+10K sh	—	—	10,000
2010-11-17	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionA Award	Chief Financial Officer	AAward	+425K sh	—	—	882,500
2010-02-19	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionA Award	Chief Financial Officer	AAward	+300K sh	—	—	457,500
2009-11-24	ELOXEloxx Pharmaceuticals, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	$0.39	−$3,900	90,875
2009-11-19	ELOXEloxx Pharmaceuticals, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−1,400 sh	—	—	100,875
2005-05-19	ELOXEloxx Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,000 sh	$2.26	+$4,520	82,335
2004-12-16	ELOXEloxx Pharmaceuticals, Inc. · Common Stock OptionsA Award	Chief Financial Officer	AAward	+20K sh	—	—	107,500

Recent filings

Accepted (ET)
Nov 224
BROOKS JOEL0001567619-19-022090
SEC(opens sec.gov)
Jul 54
BROOKS JOEL0001140361-18-031444
SEC(opens sec.gov)
Jul 54
USA TECHNOLOGIES INC0001140361-17-027208
SEC(opens sec.gov)
Jul 64
USA TECHNOLOGIES INC0001140361-16-071808
SEC(opens sec.gov)
Jul 54
USA TECHNOLOGIES INC0001140361-16-071620
SEC(opens sec.gov)
Aug 44
USA TECHNOLOGIES INC0001140361-15-029711
SEC(opens sec.gov)
Nov 204
Sevion Therapeutics, Inc.0001144204-14-069942
SEC(opens sec.gov)
Sep 164
SENESCO TECHNOLOGIES INC0001144204-13-050888
SEC(opens sec.gov)
Nov 164
BROOKS JOEL0001144204-12-063561
SEC(opens sec.gov)
May 254
BROOKS JOEL0001140361-12-027294
SEC(opens sec.gov)
Oct 44
BROOKS JOEL0001179110-11-013852
SEC(opens sec.gov)
Jul 54
BROOKS JOEL0001140361-11-035427
SEC(opens sec.gov)
Nov 194
BROOKS JOEL0001179110-10-016344
SEC(opens sec.gov)
Feb 234
BROOKS JOEL0001179110-10-003471
SEC(opens sec.gov)
Nov 244
BROOKS JOEL0001179110-09-015899
SEC(opens sec.gov)

Companies

Address

303 GEORGE STREET SUITE 420

NEW BRUNSWICK, NJ, 08901